214 related articles for article (PubMed ID: 22736789)
21. miRNA dysregulation in breast cancer.
Mulrane L; McGee SF; Gallagher WM; O'Connor DP
Cancer Res; 2013 Nov; 73(22):6554-62. PubMed ID: 24204025
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression.
Hu TB; Chen HS; Cao MQ; Guo FD; Cheng XY; Han ZB; Li MQ
Neoplasma; 2018; 65(1):49-54. PubMed ID: 29322788
[TBL] [Abstract][Full Text] [Related]
23. miR-210: a therapeutic target in cancer.
Hong L; Han Y; Zhang H; Zhao Q; Qiao Y
Expert Opin Ther Targets; 2013 Jan; 17(1):21-8. PubMed ID: 23173806
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA and miR-7 in cancer.
Hansen TB; Kjems J; Damgaard CK
Cancer Res; 2013 Sep; 73(18):5609-12. PubMed ID: 24014594
[TBL] [Abstract][Full Text] [Related]
25. Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach.
Yang Y; Chaerkady R; Beer MA; Mendell JT; Pandey A
Proteomics; 2009 Mar; 9(5):1374-84. PubMed ID: 19253296
[TBL] [Abstract][Full Text] [Related]
26. Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.
Koufaris C; Valbuena GN; Pomyen Y; Tredwell GD; Nevedomskaya E; Lau CH; Yang T; Benito A; Ellis JK; Keun HC
Oncogene; 2016 May; 35(21):2766-76. PubMed ID: 26477310
[TBL] [Abstract][Full Text] [Related]
27. A stiffness-mediated oncogenic hammer.
Ghajar CM
Sci Transl Med; 2014 May; 6(237):237fs21. PubMed ID: 24848253
[TBL] [Abstract][Full Text] [Related]
28. [SIGNIFICANCE OF NONCODING RNA IN BREAST CANCER].
Sato F
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):370-3. PubMed ID: 26845889
[TBL] [Abstract][Full Text] [Related]
29. Micro-RNAs and breast cancer.
Le Quesne J; Caldas C
Mol Oncol; 2010 Jun; 4(3):230-41. PubMed ID: 20537965
[TBL] [Abstract][Full Text] [Related]
30. Bifunctional chimera for ligand-directed photo-degradation of oncogenic microRNA.
Li C; Wang J; Wang Y; Feng Y; Li J; Zhang Y
Chem Commun (Camb); 2023 Jun; 59(49):7639-7642. PubMed ID: 37255334
[TBL] [Abstract][Full Text] [Related]
31. [Advances in Research on miR-21 and Breast Cancer].
Zhang H; Zhang Y; Zou L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):712-6. PubMed ID: 26486006
[TBL] [Abstract][Full Text] [Related]
32. miR-520h is crucial for DAPK2 regulation and breast cancer progression.
Su CM; Wang MY; Hong CC; Chen HA; Su YH; Wu CH; Huang MT; Chang YW; Jiang SS; Sung SY; Chang JY; Chen LT; Chen PS; Su JL
Oncogene; 2017 Oct; 36(41):5770. PubMed ID: 28825723
[TBL] [Abstract][Full Text] [Related]
33. New avenues in secondary and tertiary prevention of breast cancer.
Schmutzler RK
Breast Care (Basel); 2015 Feb; 10(1):6. PubMed ID: 25960718
[No Abstract] [Full Text] [Related]
34. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.
Gasparini P; Lovat F; Fassan M; Casadei L; Cascione L; Jacob NK; Carasi S; Palmieri D; Costinean S; Shapiro CL; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4536-41. PubMed ID: 24616504
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer.
Jang MH; Kim HJ; Gwak JM; Chung YR; Park SY
Hum Pathol; 2017 Oct; 68():69-78. PubMed ID: 28882698
[TBL] [Abstract][Full Text] [Related]
36. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1.
Zhang CM; Zhao J; Deng HY
J Biomed Sci; 2013 Oct; 20(1):79. PubMed ID: 24152184
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
38. Role of miR-155 in drug resistance of breast cancer.
Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.
Kong W; He L; Richards EJ; Challa S; Xu CX; Permuth-Wey J; Lancaster JM; Coppola D; Sellers TA; Djeu JY; Cheng JQ
Oncogene; 2014 Feb; 33(6):679-89. PubMed ID: 23353819
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
